We are live on ! Find out more
WC

Winmill & Co Portfolio holdings

AUM $347M
1-Year Est. Return 37.48%
This Fund
S&P 500
This Quarter Est. Return
-6.51%
1 Year Est. Return
+37.48%
3 Year Est. Return
+106.35%
5 Year Est. Return
+136.02%
10 Year Est. Return
AUM
$253M
AUM Growth
-$23.1M
Cap. Flow
-$2.97M
Cap. Flow %
-1.18%
Top 10 Hldgs %
38.58%
Holding
80
New
5
Increased
Reduced
1
Closed
5

Top Buys

Rank Stock Value
1
AMN icon
AMN Healthcare
AMN
+$4.78M
2
NEM icon
Newmont
NEM
+$2.67M
3
OLN icon
Olin
OLN
+$2.45M
4
B
Barrick Mining
B
+$330K
5
FNV icon
Franco-Nevada
FNV
+$324K

Top Sells

Rank Stock Value
1
MRNA icon
Moderna
MRNA
+$5.33M
2
INTC icon
Intel
INTC
+$3.96M
3
VNT icon
Vontier
VNT
+$1.75M
4
AGI icon
Alamos Gold
AGI
+$1.58M
5
GNW icon
Genworth Financial
GNW
+$726K

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 23.93%
2 Financials 20.77%
3 Materials 15.87%
4 Healthcare 9.3%
5 Consumer Staples 8.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGI icon
76
Alamos Gold
AGI
$12.3B
-225,000
Closed -$1.58M
INTC icon
77
Intel
INTC
$504B
-106,000
Closed -$3.96M
MRNA icon
78
Moderna
MRNA
$22.6B
-37,290
Closed -$5.33M
OR icon
79
OR Royalties Inc
OR
$5.45B
-17,500
Closed -$177K
VNT icon
80
Vontier
VNT
$4.26B
-76,000
Closed -$1.75M

Similar funds

Winmill & Co's Q3 2022 Portfolio in Review

As of Q3 2022, Winmill & Co held 80 positions worth $253M, down 8.4% from $276M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Winmill & Co's Q3 2022 filing shows 5 new, 1 reduced and 5 closed positions. Its largest new stake was AMN Healthcare: 43,620 shares worth $4.62M. The largest sale was Moderna, an estimated $5.33M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 24% of assets, down from 24% a quarter earlier, followed by Financials and Materials.

  • Winmill & Co's largest Q3 2022 buy was AMN Healthcare: 43,620 shares worth $4.62M.
  • Winmill & Co's biggest Q3 2022 reduction was Genworth Financial, cutting an estimated $726K.
  • Winmill & Co fully exited Moderna in Q3 2022, selling an estimated $5.33M.
  • Winmill & Co's ten largest holdings make up 39% of its $253M portfolio in Q3 2022.
  • Winmill & Co opened 5 new positions and closed 5 in Q3 2022.
  • Winmill & Co's portfolio value fell 8.4% quarter-over-quarter to $253M.

Based on Winmill & Co's 13F filing for Q3 2022, filed 10 Nov 2022.